Literature DB >> 8480141

Clinical features in patients with chronic muscle pain--with special reference to fibromyalgia.

S Jacobsen1, I S Petersen, B Danneskiold-Samsøe.   

Abstract

Clinical characteristics were studied in patients with chronic muscle pain, divided into three groups according to the characteristics of their pain; "fibromyalgia" (n = 23), "widespread muscle pain" (n = 21), and "regional muscle pain" (n = 28). Typical fibromyalgia features were also seen in the other groups of patients, but not to the same extent. In particular, sleep disturbance, subjective swelling, cold and exercise intolerance and low self-reported physical performance were significantly related to fibromyalgia. The major components of fibromyalgia were not wholly different compared with other European and North American studies, except for sleep disturbance and subjective swelling, which was somewhat more pronounced in this study. The most used medications in fibromyalgia patients at referral were analgesics, anxiolytic drugs and female sex hormones. Medication in fibromyalgia was not excessive and seemed appropriate compared to the other patient groups. Effects of various biases and classification criteria on the results of fibromyalgia studies are discussed. The characteristic features of fibromyalgia, its stability when diagnosed and the promotion of research and patient management justify the current classification of fibromyalgia at this stage.

Entities:  

Mesh:

Year:  1993        PMID: 8480141     DOI: 10.3109/03009749309095118

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  4 in total

1.  [How reliable are statements on extensive noninflammatory pain? Comparison of patients with fibromyalgia, backache, and other local pain].

Authors:  R Dohrenbusch; L Sampaio-Doherty; E Genth
Journal:  Schmerz       Date:  2003-10       Impact factor: 1.107

2.  Coping styles in fibromyalgia: effect of co-morbid posttraumatic stress disorder.

Authors:  Jacob N Ablin; Hagit Cohen; Lily Neumann; Zeev Kaplan; Dan Buskila
Journal:  Rheumatol Int       Date:  2007-12-06       Impact factor: 2.631

3.  Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity.

Authors:  Collin R Elsea; Daniel A Roberts; Brian J Druker; Lisa J Wood
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

4.  Impact of fibromyalgia on functioning in obese patients undergoing comprehensive rehabilitation.

Authors:  Marco Arreghini; Gian Mauro Manzoni; Gianluca Castelnuovo; Cristina Santovito; Paolo Capodaglio
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.